Investment opportunity

We are looking for funding in order to move forward with our next clinical trial. Read more below.

Why to invest in Medicortex Finland Oy?

Medicortex is bringing to Finland a new diagnostic option for clear unmet need to detect head injuries and concussion.

- Large customer potential and variable clients.

- Current company valuation ca. 6.3 M€.

- Exit planned as listing* on First North at Nasdaq Helsinki as soon as the valuation is above 10 M€.

- Four people team keeping the costs low, slim and lean organization.

* Pending BOD approval.

Investment will be used for a clinical trial sample collection.

- Basic development done including preclinical and proof-of-concept human testing.

- Patent applications and PCT filed.

- Exciting Company, won twice an innovation prize.

Go back to Investors page